Your session is about to expire
← Back to Search
Other
Fat Grafting Technique for Fecal Incontinence
N/A
Waitlist Available
Research Sponsored by Melanie Salerno, RN
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
Fecal Incontinence affects an estimated 2-20% of the general population, and up to 50% of the elderly and institutionalized population. Patients with incontinence tend to suffer in silence; they often do not seek help because of embarrassment and stigma. They often become confined to their homes because they are afraid of having an "accident". Although this is not a life-threatening condition, the psychological, emotional, and social impact can be devastating.
Eligible Conditions
- Bowel Incontinence
- Fecal Incontinence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Resolution of Fecal Incontinence Measured by Physical Exam
Resolution of Fecal Incontinence Measured by patient reported outcomes on questionnaires
Secondary study objectives
Incident of treatment related adverse events
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients with Fecal IncontinenceExperimental Treatment1 Intervention
Patients will have the opportunity to undergo adipose tissue harvesting and targeted local Injection under ultrasound guidance in muscle defects in the intersphincteric space, all around the remaining portions of the external anal sphincter, and along the course of the pudendal nerves bilaterally
Find a Location
Who is running the clinical trial?
Melanie Salerno, RNLead Sponsor
LifespanOTHER
40 Previous Clinical Trials
41,062 Total Patients Enrolled